2432 Investors following Granules India. Share this News with them.
0
Like this story, share it with millions of investors on M3
Granules pact with Dutch co PharmaMatch
Granules India has signed a memorandum of understanding (MoU) with PharmaMatch of the Netherlands, to develop, manufacture and market formulations in the European market jointly.
Granules India has signed a memorandum of understanding (MoU) with PharmaMatch of the Netherlands, to develop, manufacture and market formulations in the European market jointly.
The arrangement would kick off with the transfer of the existing marketing authorisations by PharmaMatch to the Hyderabad-based, Granules India Ltd (GIL) for products such as paracetomol.
GIL has the basic and necessary skill sets to deliver the same, according to a press release hereon Wednesday.